The much awaited anti-diabetes herbal drug, BGR-34 was launched by Council of Scientific and Industrial Research (CSIR) in Lucknow. The scientifically validated drug was launched on Sunday, the 62nd annual day of the NBRI. The commercial manufacturing and marketing will be done by M/s Aimil Pharamaceuticals Pvt Ltd, New Delhi.
The Ayurvedic based drug is a combination of natural extracts from plants, and has not side effects. The drug is for management of type-II diabetes mellitus.
The drug has been jointly developed by two CSIR laboratories, National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plant (CIMAP).
"The drug has extracts from four plants mentioned in Ayurveda and that makes it safe," said Dr AKS Rawat, senior principal scientist, NBRI. It has been tested on animals and scientific study has found it safe and effective, with clinical trials showing 67% success.
The drug boosts immune system, works as antioxidant and checks free radicals. Though there are other anti-diabetes herbal drugs in the market, 'BGR-34' has been validated scientifically.
The drug will help maintain normal blood glucose levels, reduce chances of complications due to persistent high blood glucose levels and impart a good quality life to patients with high blood sugar levels.
The drug gives hope to the diabetic patients who desires for herbal products.
View Latest News